Paper46019
Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
Barratt TM and 3 others. Lancet, 1975. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood. Papers, record 46019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclophosphamide | Major topic |
| Nephrotic Syndrome | Major topic |
| Prednisolone | Major topic |
| Administration, Oral | |
| Adolescent | |
| Albuminuria | |
| Body Height | |
| Body Weight | |
| Child | |
| Child, Preschool | |
| Complement System Proteins | |
| Creatine | |
| Drug Resistance | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Immunodiffusion | |
| Immunoglobulin G | |
| Infant | |
| Leukocyte Count | |
| Male | |
| Proteinuria | |
| Recurrence | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36625931 | The first randomized controlled trial in pediatric nephrology: the history of the International Study of Kidney Disease in Children (ISKDC). | Pediatr Nephrol | 2023 | https://conductscience.org/library/papers/36625931 | PubMed |
| 21394465 | Cyclophosphamide in steroid-dependent nephrotic syndrome. | Pediatr Nephrol | 2011 | https://conductscience.org/library/papers/21394465 | PubMed |
| 16186679 | Treatment of steroid sensitive nephrotic syndrome. | Indian J Pediatr | 2005 | https://conductscience.org/library/papers/16186679 | PubMed |
| 12883981 | The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2003 | https://conductscience.org/library/papers/12883981 | PubMed |
| 12750975 | Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. | Pediatr Nephrol | 2003 | https://conductscience.org/library/papers/12750975 | PubMed |
| 7870636 | Cyclosporin A in refractory idiopathic nephrotic syndrome: 5 years clinical experience. | Postgrad Med J | 1994 | https://conductscience.org/library/papers/7870636 | PubMed |
| 7726612 | Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. | Arch Dis Child | 1994 | https://conductscience.org/library/papers/7726612 | PubMed |
| 7337968 | The effect of chronic daily cyclophosphamide administration on established antibody responses. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/7337968 | PubMed |
| 3740921 | Minimal change nephrotic syndrome and cyclophosphamide. | Arch Dis Child | 1986 | https://conductscience.org/library/papers/3740921 | PubMed |
| 3688915 | Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie. | Arch Dis Child | 1987 | https://conductscience.org/library/papers/3688915 | PubMed |
| 3391218 | Cyclophosphamide in treatment of minimal change nephrotic syndrome. | Eur J Pediatr | 1988 | https://conductscience.org/library/papers/3391218 | PubMed |
| 2701868 | Immunosuppressive therapy in the nephrotic syndrome in children. | Pediatr Nephrol | 1989 | https://conductscience.org/library/papers/2701868 | PubMed |
| 2248508 | Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. | Arch Dis Child | 1990 | https://conductscience.org/library/papers/2248508 | PubMed |
| 2053810 | Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. | Arch Dis Child | 1991 | https://conductscience.org/library/papers/2053810 | PubMed |
| 1911150 | Kidney biopsy prior to cyclophosphamide therapy in primary nephrotic syndrome. | Pediatr Nephrol | 1991 | https://conductscience.org/library/papers/1911150 | PubMed |
| 1718684 | Management of nephrotic syndrome in childhood. | Drugs | 1991 | https://conductscience.org/library/papers/1718684 | PubMed |
| 1536727 | Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology. | Pediatr Nephrol | 1992 | https://conductscience.org/library/papers/1536727 | PubMed |
| 941352 | Vascular absorption of intravesical formalin in cyclophosphamide induced haemorrhagic cystitis. | Urol Res | 1976 | https://conductscience.org/library/papers/941352 | PubMed |
| 783212 | Problems with immunosuppressive agents in renal disease. | J Clin Pathol Suppl (R Coll Pathol) | 1975 | https://conductscience.org/library/papers/783212 | PubMed |
| 316687 | Nephrotic syndrome of childhood: malaria therapy reconsidered. | Arch Dis Child | 1979 | https://conductscience.org/library/papers/316687 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46019
GET https://conductscience.org/api/papers/v1/46019/authors